Australian University Rankings Guide

Birth Defects Research Part B: Developmental and Reproductive Toxicology (ERA Journal)

Birth Defects Research Part B: Developmental and Reproductive Toxicology is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Birth Defects Research Part B: Developmental and Reproductive Toxicology issns are issn1: 0270-3211 issn2: 1542-9733 issn3: 1542-9741.

The fields covered by Birth Defects Research Part B: Developmental and Reproductive Toxicology as part of the evaluation of Australian university research excellence are:

Paediatrics and Reproductive Medicine Research Rankings (Sub-Field)

Pharmacology and Pharmaceutical Sciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Paediatrics and Reproductive Medicine field include:

- Acta Ginecologica
- Acta Obstetricia et Gynecologica Scandinavica
- Adolescent Health Medicine and Therapeutics
- Czech Gynaecology
- Journal of Mid-life Health
- Journal of Paediatrics Obstetrics and Gynaecology (Hong Kong Edition)
- Journal of Pediatric Health Care
- Nursing Children and Young People
- Pediatric Physical Therapy
- Pediatric Transplantation
- Physical and Occupational Therapy in Pediatrics
- Reproductive Health
- Reproductive Toxicology
- The Pediatric Infectious Disease Journal
- Trends in Endocrinology and Metabolism


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4